Harmony Biosciences (NASDAQ:HRMY) 報告季度每股收益爲$1.08，高於分析師預期的$0.74，超出45.95%。 這比去年同期的$0.73每股收益增加了47.95%。 該公司報告的季度銷售額爲$2.0127億，超過了分析師預期的$2.0125億，僅超出0.01%。 這比去年同期的$1.6841億銷售額增加了19.51%。

以上內容來自Benzinga Earnings專欄，原文如下：

Harmony Biosciences (NASDAQ:HRMY) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.74 by 45.95 percent. This is a 47.95 percent increase over earnings of $0.73 per share from the same period last year. The company reported quarterly sales of $201.27 million which beat the analyst consensus estimate of $201.25 million by 0.01 percent. This is a 19.51 percent increase over sales of $168.41 million the same period last year.